Accell EVO3 (Formerly Accell A2I)
Filler, Bone Void, Osteoinduction (W/O Human Growth Factor). 510(k) K103742, from Integra Life Sciences (Irvine, CA). Product code MBP, class 2.
As of Nov 21, 2026, K103742 is an FDA 510(k) held by Integra Life Sciences, substantially equivalent on Mar 17, 2011 after 84 days, with no recalls tied to it in FDA's recall database.
- Review time: 84 days
- Recalls: 0
Accell Evo3 is intended to fill voids and gaps in the skeletal system that are not intrinsic to the stability of the bony structure. The product is indicated for use as a bone graft extender in the spine, extremities and pelvis. Accell Evo3 may also be used as a bone void filler in the posterolateral spine, extremities and pelvis.
- Acceli Dbm Family Products, 0.5CC, 1CC, 2.5CC, 5CC, 10CC, 15CC, 30CCK061880 · Isotis NV · Aug 15, 2007
- Grafton DbmK051195 · Osteotech, Inc. · Dec 16, 2005
- PliaFX FloK242799 · Lifenet Health · Nov 21, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 23, 2010
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3045
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files